Patient safety is paramount, requiring vigilant monitoring across all relevant literature sources. Jeyflex offers an inclusive approach to literature surveillance for pharmacovigilance, providing a comprehensive solution tailored to meet our clients’ specific requirements.
Expert Approach to Literature Review
Our dedicated team of literature reviewers adheres to the best practices in pharmacovigilance literature monitoring. We employ meticulously crafted search strategies, meticulously screening numerous publications to identify adverse events relevant to case processing, aggregate report authoring, and signal management.
Tailored Search Strategies
Drawing from our extensive experience, we excel in developing robust search strategies and optimizing literature queries. This enables us to conduct targeted searches across a wide array of publications, focusing on studies and information directly pertinent to the safety of your products. With your guidance, providing a list of journals and molecules of interest, Jeyflex will efficiently execute the comprehensive search process.
At Jeyflex, we understand the critical role of literature screening in maintaining a proactive pharmacovigilance system. Our tailored solutions ensure that every relevant source is meticulously examined, allowing for the timely identification and management of potential safety concerns. We are committed to upholding the highest patient safety standards through vigilant and proactive literature monitoring.
Got your own Question? Here are some options:
Contact us to learn more about our comprehensive literature screening and monitoring services and how we can tailor our solutions to your pharmacovigilance needs and regulatory standards.
Our solutions are tailored to meet your unique needs and requirements, whether you’re a small startup or a large multinational corporation. We offer a range of services, including, consulting, training, and auditing, to help you ensure that you are complying with relevant regulations and laws, and to minimize the risk of non-compliance.